Physiology Department, Faculty of Medicine, Tanta University, Tanta 31511, Egypt.
Medical Biochemistry Department, Faculty of Medicine, Tanta University, Tanta 31511, Egypt.
ACS Chem Neurosci. 2022 Jun 15;13(12):1782-1789. doi: 10.1021/acschemneuro.2c00186. Epub 2022 Jun 2.
A high-fat, high-fructose diet (HFFD) impairs cognitive functions and increases susceptibility to neurodegenerative disorders. Irisin and heat shock protein 70 (HSP70) are well known for their role in neuroprotection. The possible neuroprotective effects of fenofibrate on HFFD-induced cognitive dysfunction and the involvement of irisin and HSP70 in these effects were investigated in this study. Rats were divided into normal control, HFFD, dimethylsulfoxide+HFFD, and fenofibrate+HFFD groups. At the end of the experiment, fenofibrate treatment restored hippocampus histological characteristics to almost normal and improved HFFD-induced cognitive deficit. It reduced body weight gain and had hypolipidemic effects by significantly lowering total cholesterol, triglycerides, and low-density lipoprotein cholesterol levels while increasing high-density lipoprotein cholesterol levels. It has antioxidant and anti-inflammatory effects as it significantly reduced the hippocampal malondialdehyde, interleukin-6, and tumor necrosis factor-alpha levels, while significantly increasing the reduced glutathione level. It prevented HFFD-induced hypoxia by significantly lowering hippocampal vascular endothelial growth factor and hypoxia-inducible factor-1 alpha levels. It significantly activated the hippocampal peroxisome proliferator-activated receptor-gamma coactivator-1 alpha (PGC-1α)/irisin/brain-derived neurotrophic factor pathway. It significantly increased hippocampal HSP70 while decreasing the HSP90 levels. It enhanced synaptic plasticity by significantly upregulating the hippocampal relative gene expression. Furthermore, hippocampal irisin levels in the HFFD group were found to be positively correlated with cognitive function, hippocampal HSP70, and relative gene expression levels, while negatively correlated with hippocampal HSP90 and HIF1α levels. Therefore, fenofibrate may be used as a potential medication to treat HFFD-induced neurodegenerative disorders.
高脂肪、高果糖饮食(HFFD)会损害认知功能并增加神经退行性疾病的易感性。鸢尾素和热休克蛋白 70(HSP70)以其在神经保护中的作用而闻名。本研究旨在探讨非诺贝特对 HFFD 诱导的认知功能障碍的可能神经保护作用及其与鸢尾素和 HSP70 的关系。将大鼠分为正常对照组、HFFD 组、二甲基亚砜+HFFD 组和非诺贝特+HFFD 组。实验结束时,非诺贝特治疗使海马组织学特征几乎恢复正常,并改善了 HFFD 诱导的认知缺陷。它通过显著降低总胆固醇、甘油三酯和低密度脂蛋白胆固醇水平,同时增加高密度脂蛋白胆固醇水平,从而减轻体重增加并具有降脂作用。它具有抗氧化和抗炎作用,因为它显著降低了海马丙二醛、白细胞介素-6 和肿瘤坏死因子-α水平,同时显著增加了还原型谷胱甘肽水平。它通过显著降低海马血管内皮生长因子和缺氧诱导因子-1α水平来预防 HFFD 诱导的缺氧。它显著激活了海马过氧化物酶体增殖物激活受体-γ共激活因子-1α(PGC-1α)/鸢尾素/脑源性神经营养因子途径。它显著增加了海马 HSP70,同时降低了 HSP90 水平。它通过显著上调海马相对基因表达来增强突触可塑性。此外,在 HFFD 组中,海马鸢尾素水平与认知功能、海马 HSP70 和相对基因表达水平呈正相关,与海马 HSP90 和 HIF1α水平呈负相关。因此,非诺贝特可能被用作治疗 HFFD 诱导的神经退行性疾病的潜在药物。